293780 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Aptabio Therapeutics, Inc. is a pharmaceutical biotechnology company, which engages in the development of intractable innovative drugs based on original platform technology. It operates through the Product Sales and Other Sales divisions. The company was founded by Su-Jin Lee on July 24, 2009 and is headquartered in Yongin-si, South Korea.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
293780 has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company